We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
A comprehensive guide to Alunbrig (brigatinib) dosage and usage for ALK-positive NSCLC patients in India, covering starting doses, adjustments, and important considerations.

Dealing with a diagnosis of non-small cell lung cancer (NSCLC), especially one that is anaplastic lymphoma kinase-positive (ALK+) and has spread (metastatic), can feel overwhelming. Finding the right treatment is paramount, and for many, Alunbrig (brigatinib) has emerged as a significant option. This medication offers hope and a path forward for patients navigating this complex journey. But what exactly is Alunbrig, how does it work, and most importantly, how is it prescribed and taken? This guide aims to demystify the dosage and usage of Alunbrig, providing clear, practical information tailored for patients in India and their loved ones. We’ll explore the typical starting doses, how your doctor might adjust them, and what to do if you miss a dose or take too much. Understanding your treatment is a vital step in managing your health effectively.
Alunbrig, with its active ingredient brigatinib, is a targeted therapy. This means it's designed to specifically attack cancer cells that have a particular genetic mutation – in this case, the ALK gene. For years, ALK-positive NSCLC has presented unique challenges, but targeted treatments like Alunbrig offer a more precise approach compared to traditional chemotherapy. It's prescribed for adults with metastatic ALK-positive NSCLC who have either progressed on or are intolerant to crizotinib (another ALK inhibitor). This specificity is key; Alunbrig works by inhibiting the abnormal protein produced by the ALK gene, which helps to slow down or stop the growth of cancer cells.
The journey with Alunbrig typically begins with a carefully determined starting dose. For most patients, the initial regimen involves taking 90 mg of Alunbrig once every day for the first 7 days. This phase is often referred to as a
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026

Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026